Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
about
NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophagesCurrent Trends in Development of Liposomes for Targeting Bacterial BiofilmsAntimicrobial activity of gallium against virulent Rhodococcus equiin vitro and in vivoModulation of iron homeostasis in macrophages by bacterial intracellular pathogens.Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model.Mycobacterium tuberculosis cell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent mannerMedical applications and toxicities of gallium compounds.Replication of Neisseria meningitidis within epithelial cells requires TonB-dependent acquisition of host cell iron.Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes.The many faces of host responses to tuberculosis.Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection.Characterization of clinical and environmental Mycobacterium avium spp. isolates and their interaction with human macrophages.Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responsesLong-acting antituberculous therapeutic nanoparticles target macrophage endosomes.Iron and immunity: a double-edged sword.Iron and microbial infection.Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells.Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model.Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.Mycobacterium's arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron.Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophagesMultiple ABC transporters are involved in the acquisition of petrobactin in Bacillus anthracis.PPE Surface Proteins Are Required for Heme Utilization by Mycobacterium tuberculosis.Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition.Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.Therapeutic potential of iron chelators in diseases associated with iron mismanagement.Iron in infection and immunity.Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan.The nature of extracellular iron influences iron acquisition by Mycobacterium tuberculosis residing within human macrophages.Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death.Synchrotron X-ray fluorescence microscopy of gallium in bladder tissue following gallium maltolate administration during urinary tract infectionTargeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages.Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages.TB or not TB: that is no longer the question.Repurposing of gallium-based drugs for antibacterial therapy.Promises and failures of gallium as an antibacterial agent.Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.Potential use of gallium-doped phosphate-based glass material for periodontitis treatment.Involvement of fumarase C and NADH oxidase in metabolic adaptation of Pseudomonas fluorescens cells evoked by aluminum and gallium toxicity.
P2860
Q24305119-E789913A-6624-45BF-B886-804382498A69Q26865495-B2D6F3D5-380F-43CF-9D83-75DDFF65E25BQ28300273-100EB415-F793-42A3-ABE2-47B997692BAEQ33534484-56DF5BE7-9FD9-4BCA-8A5D-FE67ECA5EEBAQ33558904-C20264D0-118E-4D54-9A0D-0784A0F2C68FQ33822234-640959EA-87DC-4696-9B3D-861B6EFD4C53Q33965885-46AC37F3-2B4E-4EB4-B872-252237CD71AAQ34120589-DE04A22C-39EB-4FD6-B175-A61C60EF7C40Q34186778-3BB3DAC7-F626-4290-8791-1E717FBBD7D1Q34266438-34D57FAA-3E60-4D33-812C-CDF332C5C797Q34359480-79188776-A08C-438D-9421-7AA60D9B4F94Q34428984-70F70570-E997-4635-94DB-C1ECF2763A9EQ34459867-9C1F1E1B-9876-4A20-8A51-5C45E382284FQ34512904-5801A7F9-DEB7-4B9C-AB4D-72655D486E20Q34557043-A710FF1A-1C07-4FFD-850F-0FEFDDFCE42BQ34650077-FD0AED0A-128A-4BF1-9DEA-D89FB429EE1AQ35078156-61E49323-47A0-401B-9DF6-4DADF0E846A7Q35111159-850D16ED-85BA-4A1E-9B26-E351622CEFA6Q35153311-CEA22EC2-7F2B-469F-8BF2-687DAF5077BFQ35336154-F165F901-30EF-45B1-8FB7-11280175B9CFQ35670431-ECC8B855-52C1-4A74-B493-395C53A19466Q35715983-4AA2B867-0B8D-4235-B06A-07C1A83981ACQ35881671-9D99FA1D-E230-473B-9F2E-DB3DB4D7FEEBQ36259242-3934EEF3-1906-4C6D-A0DF-96712C27FB57Q36305784-EAD3C158-4152-4907-AA8B-E4C99A769A40Q36381046-53ED1A46-FC44-41A4-ACC7-ED97E3472390Q36461028-1B406FDC-1BCA-4C0B-951D-0A504F5EA2FEQ36913895-69D1BABD-D7D7-417A-B478-A3FEB1728384Q36968424-183454E4-BD50-4038-8ED0-6A7FB24BFDE8Q37117205-7281B458-CB4B-45B0-9E49-FA90B0F2B354Q37207394-559C6E9E-A20C-448D-A605-998FCDFFF8AEQ37263450-70B76F08-FFAE-4C60-88C4-1A79474E19ADQ37443661-B965E08F-3FB6-421E-9AB5-80A56C1FE7F8Q37720824-5C56648C-B080-4284-8B1B-5023E7CB62C0Q38166990-012EB38F-0E32-4B44-86E5-5D6CF026AD4AQ38188468-68F80D09-6EF2-4752-852A-BCCAB88FC8EDQ38206870-79CCE91A-FEF8-450B-A7C9-BEE0E0CCED2CQ38868528-AE33109F-9B79-4405-8205-077FB460DE58Q39038991-768CE2D0-1560-4F2C-B592-B88AD4709124Q39752431-99EB26C2-2C93-47DE-909B-08A2444B5F16
P2860
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages
@nl
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
@ast
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
@en
type
label
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages
@nl
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
@ast
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
@en
prefLabel
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages
@nl
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
@ast
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
@en
P2093
P2860
P3181
P1476
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.
@en
P2093
B E Britigan
L S Schlesinger
O Olakanmi
P2860
P304
P3181
P356
10.1128/IAI.68.10.5619-5627.2000
P407
P577
2000-10-01T00:00:00Z